Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.519 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 000000
Cost of Revenue 0.5711.8080.6850.2090.0730.044
Gross Profit -0.571-1.808-0.685-0.209-0.073-0.044
Gross Profit Ratio 000000
Reseach & Development Expenses 18.29930.38321.66211.1858.358.227
General & Administrative Expenses 18.66519.80515.827.5284.0854.513
Selling & Marketing Expenses -0.57100000
SG&A 18.66519.80515.827.5284.0854.513
Other Expenses 0.11.60.688-0.649-0.0010.028
Operating Expenses 37.06450.18837.48218.71312.43512.74
Operating Income -37.064-50.188-37.482-19.451-12.435-12.74
Operating Income Ratio 000000
Total Other Income Expenses Net 2.9631.60.688-0.649-4.3050.028
Income Before Tax -34.101-48.588-36.794-20.1-16.74-13.039
Income Before Tax Ratio 000000
Income Tax Expense 0.10.2190.670.5292.2550.299
Net Income -34.101-48.807-37.464-20.629-18.995-13.039
Net Income Ratio 000000
EPS -1.22-1.59-1.35-0.67-0.65-19.03
EPS Diluted -1.22-1.59-1.35-0.67-0.65-19.03
EBITDA -35.613-50.188-35.997-17.975-12.363-12.668
EBITDA Ratio 000000